Loading…
Loading…
RMD · NYSE · Healthcare
“With a P/E of 22.4 against $2.69 earnings, prudent investors should scrutinize whether RMD's intrinsic value justifies this premium valuation.”
— In the voice of Graham
Analyze dividend yield, payout ratio, growth history, and sustainability for income-oriented investment decisions.
Market Cap
$33.26B
P/E Ratio
22.39
Forward P/E
—
EPS
$2.69
PEG Ratio
1.55
Book Value
$43.34
Dividend Yield
0.26%
Profit Margin
27.59%
ROE
6.21%
Use the interactive dividend analyzer with pre-loaded data for Resmed Inc. Adjust discount rates, growth assumptions, and projection horizons to model different scenarios.
Pre-loaded inputs for RMD: